Opportunity to participate in research study


Help us learn how to better diagnose Parkinson’s Disease at an earlier stage.

Overview

The purpose of this study is to help identify molecules in the saliva, called microRNAs, that can serve as biomarkers for Parkinson’s disease. These biomarkers may allow earlier diagnosis and treatment of this disease. A doctor will ask each participant to perform a brief series of neurological tests, in addition to cognitive and balance tests. A small amount of saliva will then be collected in order to measure microRNA.

We offer flexible scheduling.

See printable tri-fold brochure

Quadrant Biosciences works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications.

Help us learn how to better diagnose Parkinson’s Disease at an earlier stage. Each participant is paid $25.

Adults – recently diagnosed with Parkinson’s Disease – are eligible for the study, “Molecular and functional biomarkers of Parkinson’s Disease”

CLINICAL STUDY OF PARKINSON’S DISEASE THIS STUDY MIGHT BE FOR YOU IF:

◆ You have recently been diagnosed with Parkinson’s Disease

◆ You would like to help us learn how microRNA markers change in Parkinson’s Disease & improve our understanding of the disease.

A clinical study for adults with recently diagnosed Parkinson’s Disease. MOLECULAR AND FUNCTIONAL BIOMARKERS OF PARKINSON’S DISEASE

OVERVIEW The purpose of this study is to help identify molecules in the saliva, called microRNAs, that can serve as biomarkers for Parkinson’s disease. These biomarkers may allow earlier diagnosis and treatment of this disease. A doctor will ask each participant to perform a brief series of neurological tests, in addition to cognitive and balance tests. A small amount of saliva will then be collected in order to measure microRNA. We offer flexible scheduling.

GOAL OF THIS STUDY Currently, only a very small number of biological tests are available for early diagnosis of Parkinson’s Disease, and these are not informative for all types of the disease. By finding microRNA markers with higher levels in Parkinson’s patients, we may be able to diagnose this disease at an earlier stage and also improve our understanding of the disease. We hope that by discovering new markers and earlier diagnosis of Parkinson’s disease, the quality of life of patients can be improved.

DO YOU QUALIFY? We are looking for participants recently diagnosed with Parkinson’s Disease. As a small compensation for your participation, each participant will receive $25. We will also pay for parking. FOR MORE INFORMATION or to schedule your participation, form at:

If you qualify for the study, an information packet will be mailed to you prior to your study appointment.